Showing results (1641-1650 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|October 30, 2021
Long-term survival data of patients with limited disease small cell lung cancer: a retrospective analysisKosei Doshita, Hirotsugu Kenmotsu, Shota Omori, et al.Investigational New Drugs|May 3, 2022
Autoimmune hemolytic anemia in patients with relapsed Hodgkin's lymphoma after treatment with penpulimab, a monoclonal antibody against programmed death receptor-1Yiming Tao, Jie Han, Yongsheng LiInvestigational New Drugs|January 1, 1986
Sodium azide is less suitable as a positive control of drug-induced lethality for in vitro clonogenic assaysP Lelieveld, M S Aapro, R van Lambalgen, et al.Investigational New Drugs|July 20, 2022
Mono-PEGylated thermostable Bacillus caldovelox arginase mutant (BCA-M-PEG20) induces apoptosis, autophagy, cell cycle arrest and growth inhibition in gastric cancer cellsSai-Fung Chung, Suet-Ying Tam, Chi-Fai Kim, et al.Investigational New Drugs|July 28, 2022
Effectiveness and safety of gemcitabine plus nab-paclitaxel in elderly patients with advanced pancreatic cancer: a single-center retrospective cohort studySae Ohwada, Akiko Todaka, Hiroshi Nakase, et al.Investigational New Drugs|February 5, 2016
A phase II study of cediranib, an oral VEGF inhibitor, in previously untreated patients with metastatic or recurrent malignant melanomaElaine McWhirter, Ian Quirt, Thomas Gajewski, et al.Investigational New Drugs|January 19, 2016
Effect of regulation reform on clinical trials for registering novel therapeutic agents in Taiwan: a chronological analysisI-Chen Sun, Horng-Shing Shy, Tzu-Ya LiaoInvestigational New Drugs|December 16, 2014
Phase II trial of combination therapy of gemcitabine plus anti-angiogenic vaccination of elpamotide in patients with advanced or recurrent biliary tract cancerMasato Matsuyama, H Ishii, J Furuse, et al.Investigational New Drugs|January 7, 2015
Chemotherapy in vivo against M109 murine lung carcinoma with cytochalasin B by localized, systemic, and liposomal administrationMatthew Trendowski, Joan M Mitchell, Christine M Corsette, et al.Investigational New Drugs|November 1, 1989
Activity of batracylin (NSC-320846) against solid tumors of miceP Mucci-LoRusso, L Polin, M C Bissery, et al.Pageof 372